You are viewing: Rest Of Europe Pharmaceutical Manufacturing Equipment Market analysis

The Rest Of Europe Pharmaceutical Manufacturing Equipment Market was valued at $2029.3 Million in 2026 and projected to reach to $2684.7 Million by 2031, representing a compound annual growth rate of 4.8%. Rest Of Europe's pharmaceutical manufacturing equipment market is poised for steady growth through 2031, driven by regulatory pressures and the need for facility modernization across the region.

Rest Of Europe Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • This steady growth trajectory reflects Rest Of Europe's commitment to modernizing production facilities and adopting advanced manufacturing technologies to meet stringent regulatory standards and increasing pharmaceutical demand.
  • Rest Of Europe's market expansion is driven by investments in automation, quality control systems, and compliance-focused equipment upgrades across the region's diverse pharmaceutical manufacturing base. Rest Of Europe encompasses a heterogeneous landscape of pharmaceutical manufacturers ranging from large multinational operations to specialized contract manufacturers.
  • Between 2026 and 2031, Rest Of Europe is expected to experience incremental capacity additions and technology transitions as manufacturers seek to enhance operational efficiency and reduce production costs.
  • Rest Of Europe's growth is tempered compared to global rates (6.2% CAGR) due to mature market dynamics, but the region remains strategically important for European pharmaceutical supply chains and regulatory harmonization initiatives..

Key Market Statistics

  • CAGR (2026-2031) 4.8% CAGR
  • Market Size, 2026 ~USD 2029.3 Million
  • Forecast, 2031 ~USD 2684.7 Million
  • Country Rest Of Europe

Rest Of Europe Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation Growth :

Rest Of Europe's pharmaceutical manufacturing equipment market is valued at USD 2,029.3 million in 2026 and is projected to reach USD 2,684.7 million by 2031, demonstrating consistent market expansion driven by regulatory compliance and modernization initiatives.

Steady CAGR Performance :

The region exhibits a compound annual growth rate of 4.8% from 2026 to 2031, reflecting stable market conditions and sustained investment in advanced manufacturing technologies across Rest Of Europe's pharmaceutical sector.

Regulatory Modernization Drive :

Rest Of Europe's commitment to stringent regulatory standards is accelerating the adoption of advanced manufacturing equipment, as pharmaceutical producers invest in compliance-ready facilities to meet EU and local regulatory requirements.

Technology Adoption Momentum :

The region is experiencing increased adoption of automation, precision equipment, and digital manufacturing solutions, positioning Rest Of Europe as a growing hub for modernized pharmaceutical production infrastructure.

Rest Of Europe Pharmaceutical Manufacturing Equipment Market Dynamics

  • Manufacturers are increasingly investing in advanced technologies to enhance production efficiency, ensure product quality, and maintain compliance with evolving pharmaceutical standards.
  • The 4.8% CAGR reflects a balanced market with consistent demand from both established and emerging pharmaceutical producers seeking to upgrade their manufacturing capabilities. The outlook for Rest Of Europe remains positive as the region continues to strengthen its pharmaceutical manufacturing base.
  • Investment in automation, quality control systems, and sustainable manufacturing equipment is expected to accelerate.
  • Additionally, the region's focus on reducing production costs while maintaining regulatory compliance will drive equipment upgrades and replacements, supporting sustained market growth through the forecast period..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • Rest Of Europe's pharmaceutical manufacturing equipment market will grow from USD 2,029.3M (2026) to USD 2,684.7M (2031) at a 4.8% CAGR.
    • Rest Of Europe's market growth is driven by regulatory compliance requirements, automation adoption, and modernization of aging production infrastructure.
    • Rest Of Europe's 4.8% CAGR is lower than the global 6.2% CAGR, reflecting a mature but stable market with incremental expansion opportunities.
    • Rest Of Europe's pharmaceutical manufacturers are increasingly investing in quality control systems and advanced equipment to maintain competitive positioning in European supply chains.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    Rest Of Europe Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Equipment Manufacturers & Suppliers : Pharmaceutical equipment manufacturers need Rest Of Europe-specific market data to identify growth opportunities, understand regional demand patterns, and develop localized product strategies for this steady-growth market.
    • Pharmaceutical Producers & Operators : Pharma companies operating in Rest Of Europe require market intelligence to benchmark capital expenditure plans, evaluate equipment investment timing, and align facility modernization with regional growth trends.
    • Private Equity & Investment Firms : Investors evaluating pharmaceutical manufacturing assets in Rest Of Europe need precise market sizing and growth forecasts to assess portfolio opportunities, valuation multiples, and long-term return potential in the region.
    • Consultants & Business Strategists : Management consultants advising pharmaceutical and equipment companies require Rest Of Europe market data to develop regional strategies, support M&A decisions, and provide evidence-based recommendations to clients.
    • Regulatory & Compliance Officers : Compliance professionals in Rest Of Europe's pharmaceutical sector need market insights on regulatory-driven equipment adoption trends to inform facility upgrade priorities and ensure alignment with industry modernization standards.

    Key Companies in the Rest Of Europe Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise valuation data specific to Rest Of Europe's pharmaceutical manufacturing equipment market, including 2026 baseline (USD 2,029.3M) and 2031 projections (USD 2,684.7M), enabling accurate business planning and investment decisions.
    • Growth Rate Intelligence : Understand Rest Of Europe's 4.8% CAGR trajectory compared to the global 6.2% benchmark, identifying regional growth dynamics and market maturity levels to inform competitive positioning strategies.
    • Regulatory & Compliance Insights : Gain actionable intelligence on how stringent Rest Of Europe regulatory standards are driving equipment modernization, helping suppliers tailor solutions to regional compliance requirements and market demands.
    • Investment & Expansion Strategy : Leverage Rest Of Europe-specific market data to identify expansion opportunities, assess market attractiveness, and prioritize resource allocation across the region's pharmaceutical manufacturing sector.
    • Competitive Landscape Analysis : Access detailed insights into Rest Of Europe's market dynamics, technology adoption trends, and growth drivers to benchmark performance, identify competitive gaps, and develop targeted market entry or growth strategies.

    Frequently asked questions

    What is the market size of pharmaceutical manufacturing equipment in Rest Of Europe in 2026?

    Rest Of Europe's pharmaceutical manufacturing equipment market is estimated at USD 2,029.3 million in 2026.

    What is the projected market size for Rest Of Europe in 2031?

    Rest Of Europe's pharmaceutical manufacturing equipment market is forecast to reach USD 2,684.7 million by 2031.

    What is the CAGR for Rest Of Europe's pharmaceutical manufacturing equipment market?

    Rest Of Europe's pharmaceutical manufacturing equipment market is expected to grow at a CAGR of 4.8% from 2026 to 2031.

    How does Rest Of Europe's growth rate compare to the global market?

    Rest Of Europe's CAGR of 4.8% is lower than the global CAGR of 6.2%, indicating a more mature market with steady but incremental growth.

    What factors are driving growth in Rest Of Europe's pharmaceutical manufacturing equipment market?

    Rest Of Europe's market growth is driven by regulatory compliance needs, automation investments, facility modernization, and quality control system upgrades among pharmaceutical manufacturers.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status